Lista de obras -

274. MIR137 Influences White Matter Fractional Anisotropy and Cortical Surface Area in Individuals with High Genetic Risk for Psychosis

A hypothesis-driven association study of 28 nuclear-encoded mitochondrial genes with antipsychotic-induced weight gain in schizophrenia

artículo científico publicado en 2013

Alcohol and Dementia - What is the Link? A Systematic Review

scientific article published on 09 January 2020

Association Study of Serotonin 3 Receptor Subunit Gene Variants in Antipsychotic-Induced Weight Gain

artículo científico publicado en 2017

Association between the -2548G/A polymorphism of the leptin gene and antipsychotic-induced weight gain: Analysis of the CATIE sample and meta-analysis

scientific article published on 23 April 2020

Association of Dystrobrevin-Binding Protein 1 Polymorphisms with Sustained Attention and Set-Shifting in Schizophrenia Patients

artículo científico publicado en 2016

Association of a functional polymorphism in neuropeptide Y with antipsychotic-induced weight gain in schizophrenia patients.

artículo científico publicado en 2013

Association of orexin receptor polymorphisms with antipsychotic-induced weight gain

artículo científico publicado en 2015

Association study between the neurexin-1 gene and tardive dyskinesia

artículo científico publicado en 2017

Association study of GABAA α2 receptor subunit gene variants in antipsychotic-associated weight gain

artículo científico publicado en 2015

Clinical and sociodemographic Differences Between Patients with and without Migration Background in a Psychiatric Outpatient Service

artículo científico publicado en 2018

Cortical surface-based threshold-free cluster enhancement and cortexwise mediation

artículo científico publicado en 2017

Exploratory study on association of genetic variation in TBC1D1 with antipsychotic-induced weight gain

artículo científico publicado en 2013

F1. GENOME-WIDE ASSOCIATION STUDIES SUGGESTED ASSOCIATION BETWEEN DGKB AND ANTIPSYCHOTIC INDUCED WEIGHT GAIN IN EUROPEANS AND AFRICAN AMERICANS.

artículo científico publicado en 2018

Fat mass- and obesity-associated (FTO) gene and antipsychotic-induced weight gain: an association study

artículo científico publicado en 2014

From pharmacogenetics to imaging pharmacogenetics: elucidating mechanisms of antidepressant response.

artículo científico publicado en 2017

Genetic testing for CYP2D6 and CYP2C19 suggests improved outcome for antidepressant and antipsychotic medication

artículo científico publicado en 2018

Genetic variation in CYP3A43 is associated with response to antipsychotic medication

artículo científico publicado en 2014

Genetic variation in the GCG and in the GLP1R genes and antipsychotic-induced weight gain

artículo científico publicado en 2014

Genetics and Personalized Medicine in Antidepressant Treatment ⬇️

artículo científico publicado el 1 de enero de 2012

Impact of histamine receptors H1 and H3 polymorphisms on antipsychotic-induced weight gain

artículo científico publicado en 2016

Investigation of TSPO variants in schizophrenia and antipsychotic treatment outcomes

artículo científico publicado en 2015

Investigation of melanocortin system gene variants in antipsychotic-induced weight gain

artículo científico publicado en 2014

Multimodal neuroimaging measures and intelligence influence pedophile child sexual offense behavior

artículo científico publicado en 2018

No evidence for a role of the peroxisome proliferator-activated receptor gamma (PPARG) and adiponectin (ADIPOQ) genes in antipsychotic-induced weight gain

artículo científico publicado en 2014

Pharmacogenetics and Imaging-Pharmacogenetics of Antidepressant Response: Towards Translational Strategies.

artículo científico publicado en 2016

Pharmacogenetics of Obsessive–Compulsive Disorders ⬇️

artículo científico publicado el 1 de enero de 2012

Pharmacogenetics of antidepressant treatment in obsessive-compulsive disorder: an update and implications for clinicians

artículo científico

Pharmacogenetics of antipsychotics

artículo científico publicado en 2014

Physicians' opinions following pharmacogenetic testing for psychotropic medication.

artículo científico publicado en 2015

Quantitative historical analysis uncovers a single dimension of complexity that structures global variation in human social organization.

artículo científico publicado en 2017

Reply to Tosh et al.: Quantitative analyses of cultural evolution require engagement with historical and archaeological research

article published in the Proceedings of the National Academy of Sciences of the United States of America

Role of 5-HT(2C) receptor gene variants in antipsychotic-induced weight gain

artículo científico publicado en 2011

The AmpliChip® CYP450 test and response to treatment in schizophrenia and obsessive compulsive disorder: a pilot study and focus on cases with abnormal CYP2D6 drug metabolism

artículo científico publicado en 2012

The influence of MIR137 on white matter fractional anisotropy and cortical surface area in individuals with familial risk for psychosis

artículo científico publicado en 2017

Towards the implementation of CYP2D6 and CYP2C19 genotypes in clinical practice: update and report from a pharmacogenetic service clinic

artículo científico

[The Influence of Residence Status on Psychiatric Symptom Load of Asylum Seekers in Germany]

scientific article published on 12 December 2018

Lista de obras de

274. MIR137 Influences White Matter Fractional Anisotropy and Cortical Surface Area in Individuals with High Genetic Risk for Psychosis

A hypothesis-driven association study of 28 nuclear-encoded mitochondrial genes with antipsychotic-induced weight gain in schizophrenia

Alcohol and Dementia - What is the Link? A Systematic Review

Association Study of Serotonin 3 Receptor Subunit Gene Variants in Antipsychotic-Induced Weight Gain

Association between the -2548G/A polymorphism of the leptin gene and antipsychotic-induced weight gain: Analysis of the CATIE sample and meta-analysis

Association of Dystrobrevin-Binding Protein 1 Polymorphisms with Sustained Attention and Set-Shifting in Schizophrenia Patients

Association of a functional polymorphism in neuropeptide Y with antipsychotic-induced weight gain in schizophrenia patients.

Association of orexin receptor polymorphisms with antipsychotic-induced weight gain

Association study between the neurexin-1 gene and tardive dyskinesia

Association study of GABAA α2 receptor subunit gene variants in antipsychotic-associated weight gain

Clinical and sociodemographic Differences Between Patients with and without Migration Background in a Psychiatric Outpatient Service

Cortical surface-based threshold-free cluster enhancement and cortexwise mediation

Exploratory study on association of genetic variation in TBC1D1 with antipsychotic-induced weight gain

F1. GENOME-WIDE ASSOCIATION STUDIES SUGGESTED ASSOCIATION BETWEEN DGKB AND ANTIPSYCHOTIC INDUCED WEIGHT GAIN IN EUROPEANS AND AFRICAN AMERICANS.

Fat mass- and obesity-associated (FTO) gene and antipsychotic-induced weight gain: an association study

From pharmacogenetics to imaging pharmacogenetics: elucidating mechanisms of antidepressant response.

Genetic testing for CYP2D6 and CYP2C19 suggests improved outcome for antidepressant and antipsychotic medication

Genetic variation in CYP3A43 is associated with response to antipsychotic medication

Genetic variation in the GCG and in the GLP1R genes and antipsychotic-induced weight gain

Genetics and Personalized Medicine in Antidepressant Treatment ⬇️

Impact of histamine receptors H1 and H3 polymorphisms on antipsychotic-induced weight gain

Investigation of TSPO variants in schizophrenia and antipsychotic treatment outcomes

Investigation of melanocortin system gene variants in antipsychotic-induced weight gain

Multimodal neuroimaging measures and intelligence influence pedophile child sexual offense behavior

No evidence for a role of the peroxisome proliferator-activated receptor gamma (PPARG) and adiponectin (ADIPOQ) genes in antipsychotic-induced weight gain

Pharmacogenetics and Imaging-Pharmacogenetics of Antidepressant Response: Towards Translational Strategies.

Pharmacogenetics of Obsessive–Compulsive Disorders ⬇️

Pharmacogenetics of antidepressant treatment in obsessive-compulsive disorder: an update and implications for clinicians

Pharmacogenetics of antipsychotics

Physicians' opinions following pharmacogenetic testing for psychotropic medication.

Quantitative historical analysis uncovers a single dimension of complexity that structures global variation in human social organization.

Reply to Tosh et al.: Quantitative analyses of cultural evolution require engagement with historical and archaeological research

Role of 5-HT(2C) receptor gene variants in antipsychotic-induced weight gain

The AmpliChip® CYP450 test and response to treatment in schizophrenia and obsessive compulsive disorder: a pilot study and focus on cases with abnormal CYP2D6 drug metabolism

The influence of MIR137 on white matter fractional anisotropy and cortical surface area in individuals with familial risk for psychosis

Towards the implementation of CYP2D6 and CYP2C19 genotypes in clinical practice: update and report from a pharmacogenetic service clinic

[The Influence of Residence Status on Psychiatric Symptom Load of Asylum Seekers in Germany]